IMV

YTD

ALL

Why Robinhood?

You can watch IMV and buy or sell other stocks, ETFs, and their options commission-free!

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.

CEO

Andrew Hall

CEOAndrew Hall

Employees

—

Employees—

Headquarters

Dartmouth, Nova Scotia

HeadquartersDartmouth, Nova Scotia

Founded

2007

Founded2007

Employees

—

Employees—

IMV Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

0.10

Average volume0.10

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0195

52 Week high$0.0195

52 Week low

—

52 Week low—

Stock Snapshot

As of today, IMV(IMV) shares are valued at $0.82.

IMV(IMV) stock opened on 2026-02-04 at —. The price climbed to — and dipped to —.

The IMV(IMV)'s current trading volume is 0, compared to an average daily volume of 0.1.

People also own

Based on the portfolios of people who own IMV. This list is generated using Robinhood data, and it’s not a recommendation.

Virgin Galactic Holdings

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.